This inventor holds 1 USPTO granted patent. Top assignee: Cornell University. Active years: 2019.
Company Filing History:
Years Active: 2019
Title: Nathan O'Connor: Innovator in Ophthalmic Treatments
Introduction
Nathan O'Connor is a notable inventor based in New York, NY (US). He has made significant contributions to the field of ophthalmology, particularly in the treatment of retinal diseases. His innovative approach focuses on the inhibition of mast cells, which play a crucial role in various ocular conditions.
Latest Patents
Nathan O'Connor holds a patent for "Mast cell inhibition in diseases of the retina and vitreous." This application discloses methods for treating or preventing ophthalmic retinal vascular permeability, angiogenic, or fibroproliferative diseases. The patent outlines a composition that can inhibit mast cell migration, proliferation, or secretion in the vitreous or retina, providing a potential breakthrough in ophthalmic treatments. He has 1 patent to his name.
Career Highlights
O'Connor is affiliated with Cornell University, where he conducts research and develops innovative solutions for eye-related disorders. His work has garnered attention for its potential to improve patient outcomes in ophthalmology.
Collaborations
Nathan collaborates with Randi B Silver, contributing to advancements in their shared field of research. Their partnership exemplifies the importance of teamwork in scientific innovation.
Conclusion
Nathan O'Connor's contributions to ophthalmology through his innovative patent highlight the potential for new treatments in retinal diseases. His work at Cornell University continues to pave the way for advancements in eye care.